First Time Loading...

Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 38.71 USD -1.73% Market Closed
Updated: May 16, 2024

EV/S
Enterprise Value to Sales

1 036.8
Current
48.2
Median
7.5
Industry
Higher than median
Higher than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
1 036.8
=
Enterprise Value
4.7B
/
Revenue
4.6m
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
699.2
2-Years Forward
EV/S
836.4
3-Years Forward
EV/S
218.8

See Also

Discover More